Fig. 2From: Economic impact of Juvenile Idiopathic Arthritis: a systematic reviewTotal, direct, and indirect costs reported on eligible studies. Notes: References are shown in parenthesis above the year of publication. Costs are adjusted to inflation and converted to US Dollar. Based on exchange rate on December 31, 2019. Europe describes a study that includes patients from Germany, Italy, Spain, France, United Kingdom, Bulgaria, and Sweden. INT describes a study that includes patients from France, Germany, Netherlands, United Kingdom, and United States of America. NL: Netherlands. GER: Germany. USA: United States of America. UK: United KingdomBack to article page